Philip Harraka

Philip Harraka is a Research Fellow at Monash University's Faculty of Medicine, affiliated with the Victorian Heart Institute and Monash Health. His work spans medical genetics, cancer genomics, and interdisciplinary connections between renal, ocular, and hematological disorders.

His research focuses on genetic variant curation (particularly ACMG-compliant classification), cancer predisposition syndromes, and cross-system manifestations of genetic disorders. Recent work integrates ophthalmic, renal, and hematopoietic phenotypes to elucidate shared pathogenic mechanisms, especially in complement-mediated diseases and cancer genetics.

His publication trends reveal strong emphasis on collaborative large-scale genomic studies (e.g., BRIDGES breast cancer dataset), non-invasive diagnostic methods (saliva DNA for clonal hematopoiesis), and multisystem disease characterization linking renal tubulopathies to ocular manifestations. Keywords consistently include variant curation, cancer genetics, and complement system dysregulation.

• Frances Elizabeth Thompson Trust Scholarship for academic merit (2017)

Harraka actively contributes to academic governance as Biocurator for the ENIGMA BRCA1/2 Variant Curation Expert Panel (2024), Victorian Committee Lead Symposium Coordinator (2020-2022), and former Vice President (2019-2020). His external engagements focus on genetic variant standardization and multidisciplinary clinical research coordination.

He leads research within Monash Health's Victorian Heart Institute, working on genomic applications in cardiovascular and systemic diseases through collaborations with the Australian Breast Cancer Family Registry (kConFab) and international consortia.